Tandem Diabetes snags FDA approval for interoperable insulin pump software
Tandem Diabetes’ technology will create a new approval pathway for predictive dosing software that can be used with other devices.
Tandem Diabetes’ technology will create a new approval pathway for predictive dosing software that can be used with other devices.
The San Diego-based company has is in the midst of one of the most precipitous turnarounds in the medical device industry and is well positioned to grow alongside the expanding insulin pump market.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
It’s probably not often that the delivery of a new insulin pump prompts a diabetic to upload a YouTube video of her breathlessly unwrapping the box. Over the nearly 8 minute video, she repeatedly gushes over the device and its features. “Oh my gosh, I am so excited,” says Sarah who goes by the username […]
Tandem Diabetes Care Inc., a San Diego, medical device startup that has developed the first touch-screen insulin delivery system, has raised $36.4 million in its quest to garner $50 million.